Whelan, K., Thomas, S., Pothuri, B., Bae-Jump, V., Borden, L., Thaker, P., … Secord, A. A. (2023). O3 TP53-mutated endometrial cancers and associations with race and survival outcomes. In Gynecologic Oncology (Vol. 173, pp. S2–S3). Elsevier BV. https://doi.org/10.1016/j.ygyno.2023.05.020

Whelan, Karley, Samantha Thomas, Bhavana Pothuri, Victoria Bae-Jump, Lindsay Borden, Premal Thaker, Paulina Haight, et al. “O3 TP53-mutated endometrial cancers and associations with race and survival outcomes.” In Gynecologic Oncology, 173:S2–3. Elsevier BV, 2023. https://doi.org/10.1016/j.ygyno.2023.05.020.

Whelan K, Thomas S, Pothuri B, Bae-Jump V, Borden L, Thaker P, et al. O3 TP53-mutated endometrial cancers and associations with race and survival outcomes. In: Gynecologic Oncology. Elsevier BV; 2023. p. S2–3.

Whelan, Karley, et al. “O3 TP53-mutated endometrial cancers and associations with race and survival outcomes.” Gynecologic Oncology, vol. 173, Elsevier BV, 2023, pp. S2–3. Crossref, doi:10.1016/j.ygyno.2023.05.020.

Whelan K, Thomas S, Pothuri B, Bae-Jump V, Borden L, Thaker P, Haight P, Arend R, Ko E, Jackson A, Corr B, Konecny G, Wright J, Duska L, Dillon M, Lightfoot M, Newton M, Washington C, Mullen M, Cosgrove C, Horsono A, Powell K, Herzog T, Salani R, Secord AA. O3 TP53-mutated endometrial cancers and associations with race and survival outcomes. Gynecologic Oncology. Elsevier BV; 2023. p. S2–S3.